Stay updated on Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial page.

Latest updates to the Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial page
- Check3 days agoChange DetectedAdded a 2026 Pan-Asian subgroup analysis paper on EV-302 and removed the online-ahead-of-print version of the same article from the Publications list.SummaryDifference0.0%

- Check10 days agoChange DetectedRevision indicator updated: added Revision v3.5.0 and removed Revision v3.4.3.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision updated to v3.4.2 from v3.4.1. This is a minor UI/system update with no impact on study content, eligibility, or results; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check53 days agoChange DetectedMinor version update from v3.4.0 to v3.4.1 with no visible changes to study content, eligibility, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check67 days agoChange DetectedAdded a Pan-Asian subgroup publication for EV-302; glossary display is now available, and the page revision updated to v3.4.0.SummaryDifference0.1%

Stay in the know with updates to Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial page.